{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:01:24Z","timestamp":1761310884115},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1475-2875-12-250","type":"journal-article","created":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T10:14:27Z","timestamp":1374056067000},"source":"Crossref","is-referenced-by-count":37,"title":["Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia"],"prefix":"10.1186","volume":"12","author":[{"given":"Birgit","family":"Schramm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parastou","family":"Valeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S","family":"Mazinda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretxu","family":"Pinoges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Sundaygar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yah M","family":"Zolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel J","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Comte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Bruneel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Branger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Jullien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenaelle","family":"Carn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Ren\u00e9","family":"Kiechel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe J","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,17]]},"reference":[{"key":"2900_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","volume":"77","author":"F Nosten","year":"2007","unstructured":"Nosten F, White NJ: Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007, 77: 181-192.","journal-title":"Am J Trop Med Hyg"},{"key":"2900_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1475-2875-6-150","volume":"6","author":"P Brasseur","year":"2007","unstructured":"Brasseur P, Agnamey P, Gaye O, Vaillant M, Taylor WR, Olliaro PL: Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Senegal. Malar J. 2007, 6: 150-10.1186\/1475-2875-6-150.","journal-title":"Malar J"},{"key":"2900_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.4269\/ajtmh.2011.11-0069","volume":"85","author":"M Makanga","year":"2011","unstructured":"Makanga M, Bassat Q, Falade CO, Premji ZG, Krudsood S, Hunt P, Walter V, Beck HP, Marrast AC, Cousin M, Rosenthal PJ: Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis. Am J Trop Med Hyg. 2011, 85: 793-804. 10.4269\/ajtmh.2011.11-0069.","journal-title":"Am J Trop Med Hyg"},{"key":"2900_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1475-2875-8-48","volume":"8","author":"SB Sirima","year":"2009","unstructured":"Sirima SB, Tiono AB, Gansan\u00e9 A, Diarra A, Ou\u00e9draogo A, Konat\u00e9 AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WR: The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar J. 2009, 8: 48-10.1186\/1475-2875-8-48.","journal-title":"Malar J"},{"key":"2900_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0140-6736(86)92371-8","volume":"1","author":"CS Hatton","year":"1986","unstructured":"Hatton CS, Peto TE, Bunch C, Pasvol G, Russell SJ, Singer CR, Edwards G, Winstanley P: Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet. 1986, 1: 411-414.","journal-title":"Lancet"},{"key":"2900_CR6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4269\/ajtmh.2007.77.14","volume":"77","author":"LN Markham","year":"2007","unstructured":"Markham LN, Giostra E, Hadengue A, Rossier M, Rebsamen M, Desmeules J: Emergency liver transplantation in amodiaquine-induced fulminant hepatitis. Am J Trop Med Hyg. 2007, 77: 14-15.","journal-title":"Am J Trop Med Hyg"},{"key":"2900_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/bmj.292.6522.721","volume":"292","author":"KA Neftel","year":"1986","unstructured":"Neftel KA, Woodtly W, Schmid M, Frick PG, Fehr J: Amodiaquine induced agranulocytosis and liver damage. BMJ. 1986, 292: 721-723. 10.1136\/bmj.292.6522.721.","journal-title":"BMJ"},{"key":"2900_CR8","first-page":"1","volume":"17","author":"AK Akpalu Jr","year":"2011","unstructured":"Akpalu AK, Nyame PK, Dodoo ANO: Amodiaquine-induced dystonic reactions: case reports and implications for policy change in Ghana. Int J Risk Saf Med. 2011, 17: 1-4.","journal-title":"Int J Risk Saf Med"},{"key":"2900_CR9","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1086\/657402","volume":"51","author":"D Bethell","year":"2010","unstructured":"Bethell D, Se Y, Lon C, Socheat D, Saunders D, Teja-Isavadharm P, Khemawoot P, Darapiseth S, Lin J, Sriwichai S, Kuntawungin W, Surasri S, Lee SJ, Sarim S, Tyner S, Smith B, Fukuda MM: Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute Plasmodium falciparum malaria. Clin Infect Dis. 2010, 51: e105-e114. 10.1086\/657402.","journal-title":"Clin Infect Dis"},{"key":"2900_CR10","first-page":"5","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC): Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria--worldwide, 2010\u20132012. MMWR Morb Mortal Wkly Rep. 2013, 62: 5-8.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2900_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1475-2875-8-125","volume":"8","author":"JL Ndiaye","year":"2009","unstructured":"Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O: Randomized, multicentre assessment of the efficacy and safety of ASAQ\u2013a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J. 2009, 8: 125-10.1186\/1475-2875-8-125.","journal-title":"Malar J"},{"key":"2900_CR12","doi-asserted-by":"publisher","first-page":"e1001119","DOI":"10.1371\/journal.pmed.1001119","volume":"8","author":"The Four Artemisinin-Based Combinations (4ABC) Study Group","year":"2011","unstructured":"The Four Artemisinin-Based Combinations (4ABC) Study Group: A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Med. 2011, 8: e1001119-10.1371\/journal.pmed.1001119.","journal-title":"PLoS Med"},{"key":"2900_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1475-2875-12-251","volume":"12","author":"B Schramm","year":"2013","unstructured":"Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R, Pinoges L, Dhorda M, Boum Y, Sundaygar T, Zolia YM, Jones JJ, Comte E, Houz\u00e9 P, Jullien V, Carn G, Kiechel JR, Ashley EA, Gu\u00e9rin PJ: Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial. Malaria Journal. 2013, 12: 251-10.1186\/1475-2875-12-251.","journal-title":"Malaria Journal"},{"key":"2900_CR14","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization (WHO)","year":"2006","unstructured":"World Health Organization (WHO): Guidelines for the treatment of malaria. 2006, Document no: WHO\/HTM\/MAL\/2006.1108"},{"key":"2900_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jpba.2007.07.015","volume":"45","author":"D Blessborn","year":"2007","unstructured":"Blessborn D, Romsing S, Annerberg A, Sundquist D, Bjorkman A, Lindegardh N, Bergqvist Y: Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. J Pharm Biomed Anal. 2007, 45: 282-287. 10.1016\/j.jpba.2007.07.015.","journal-title":"J Pharm Biomed Anal"},{"key":"2900_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jchromb.2009.02.006","volume":"877","author":"EM Hodel","year":"2009","unstructured":"Hodel EM, Zanolari B, Mercier T, Biollaz J, Keiser J, Olliaro P, Genton B, Decosterd LA: A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877: 867-886. 10.1016\/j.jchromb.2009.02.006.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2900_CR17","first-page":"e6","volume-title":"ICH harmonized tripartite guideline for good clinical practice","author":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use","year":"1996","unstructured":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH harmonized tripartite guideline for good clinical practice. 1996, ICH, e6-\n                    http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6_R1\/Step4\/E6_R1__Guideline.pdf\n                    \n                  ,"},{"key":"2900_CR18","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE), Version 3.0","author":"Cancer Therapy Evaluation Program (CTEP)","year":"2006","unstructured":"Cancer Therapy Evaluation Program (CTEP): Common Terminology Criteria for Adverse Events (CTCAE), Version 3.0. 2006, Bethesda, US: Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institute of Health (NIH), Department of Health and Human Services (DHHS)"},{"key":"2900_CR19","first-page":"2","volume-title":"WHO toxicity grading scale for determining the severity of adverse events. Appendices: Division of Microbiology and Infectious diseases (DMID) toxicity tables: adult toxicity table May 2001; Pediatric toxicity table February 2003","author":"Division of Microbiology and Infectious Diseases","year":"2003","unstructured":"Division of Microbiology and Infectious Diseases: WHO toxicity grading scale for determining the severity of adverse events. Appendices: Division of Microbiology and Infectious diseases (DMID) toxicity tables: adult toxicity table May 2001; Pediatric toxicity table February 2003. 2003, Bethesda, US: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), 2-6."},{"key":"2900_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1473-3099(11)70339-5","volume":"12","author":"R McGready","year":"2011","unstructured":"McGready R, Lee S, Wiladphaingern J, Ashley E, Rijken M, Boel M, Simpson JA, Paw MK, Pimanpanarak M, Mu O, Singhasivanon P, White NJ, Nosten FH: Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis. 2011, 12: 388-396.","journal-title":"Lancet Infect Dis"},{"key":"2900_CR21","first-page":"CD007483","volume":"3","author":"D Sinclair","year":"2009","unstructured":"Sinclair D, Zani B, Donegan S, Olliaro P, Garner P: Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009, 3: CD007483-","journal-title":"Cochrane Database Syst Rev"},{"key":"2900_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1475-2875-11-25","volume":"11","author":"J Zwang","year":"2012","unstructured":"Zwang J, Ndiaye JL, Djimde A, Dorsey G, Martensson A, Karema C, Olliaro P: Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa. Malar J. 2012, 11: 25-10.1186\/1475-2875-11-25.","journal-title":"Malar J"},{"key":"2900_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1365-2249.1998.00586.x","volume":"112","author":"JA Kurtzhals","year":"1998","unstructured":"Kurtzhals JA, Reimert CM, Tette E, Dunyo SK, Koram KA, Akanmori BD, Nkrumah FK, Hviid L: Increased eosinophil activity in acute Plasmodium falciparum infection\u2013association with cerebral malaria. Clin Exp Immunol. 1998, 112: 303-307. 10.1046\/j.1365-2249.1998.00586.x.","journal-title":"Clin Exp Immunol"},{"key":"2900_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1475-2875-7-127","volume":"7","author":"GO Adjei","year":"2008","unstructured":"Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ: Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malar J. 2008, 7: 127-10.1186\/1475-2875-7-127.","journal-title":"Malar J"},{"key":"2900_CR25","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1001\/jama.297.20.2210","volume":"297","author":"G Dorsey","year":"2007","unstructured":"Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ: Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007, 297: 2210-2219. 10.1001\/jama.297.20.2210.","journal-title":"JAMA"},{"key":"2900_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1475-2875-7-106","volume":"7","author":"C Maiteki-Sebuguzi","year":"2008","unstructured":"Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG: Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Malar J. 2008, 7: 106-10.1186\/1475-2875-7-106.","journal-title":"Malar J"},{"key":"2900_CR27","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1086\/591459","volume":"198","author":"KE Dooley","year":"2008","unstructured":"Dooley KE, Flexner C, Andrade AS: Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries. J Infect Dis. 2008, 198: 948-961. 10.1086\/591459.","journal-title":"J Infect Dis"},{"key":"2900_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1086\/529192","volume":"46","author":"AF Gasasira","year":"2008","unstructured":"Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G: High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Clin Infect Dis. 2008, 46: 985-991. 10.1086\/529192.","journal-title":"Clin Infect Dis"},{"key":"2900_CR29","volume-title":"UNAIDS Report on the global AIDS Epidemic 2012","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2012","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS): UNAIDS Report on the global AIDS Epidemic 2012. 2012, Geneva: UNAIDS, Document no: UNAIDS\/JC2417E"},{"key":"2900_CR30","first-page":"608","volume":"15","author":"B Faye","year":"2010","unstructured":"Faye B, Offianan AT, Ndiaye JL, Tine RC, Toure W, Djoman K, Sylla K, Ndiaye PS, Penali L, Gaye O: Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Trop Med Int Health. 2010, 15: 608-613.","journal-title":"Trop Med Int Health"},{"key":"2900_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1475-2875-10-237","volume":"10","author":"JL Ndiaye","year":"2011","unstructured":"Ndiaye JL, Faye B, Gueye A, Tine R, Ndiaye D, Tchania C, Ndiaye I, Barry A, Ciss\u00e9 B, Lameyre V, Gaye O: Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Malar J. 2011, 10: 237-10.1186\/1475-2875-10-237.","journal-title":"Malar J"},{"key":"2900_CR32","first-page":"370","volume":"59","author":"S Fitoussi","year":"2009","unstructured":"Fitoussi S, Thang C, Lesauvage E, Barre J, Charron B, Filali-Ansary A, Lameyre V: Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study. Arzneimittelforschung. 2009, 59: 370-376.","journal-title":"Arzneimittelforschung"},{"key":"2900_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1475-2875-7-107","volume":"7","author":"SG Staedke","year":"2008","unstructured":"Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO: Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. Malar J. 2008, 7: 107-10.1186\/1475-2875-7-107.","journal-title":"Malar J"},{"key":"2900_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/1475-2875-11-260","volume":"11","author":"J Zwang","year":"2012","unstructured":"Zwang J, Dorsey G, Djimde A, Karema C, Martensson A, Ndiaye JL, Sirima SB, Olliaro P: Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa. Malar J. 2012, 11: 260-10.1186\/1475-2875-11-260.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-12-250\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:36:25Z","timestamp":1548117385000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-12-250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,17]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2900"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-12-250","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,17]]},"article-number":"250"}}